Volume 9, Number 2—February 2003
Research
Equine Amplification and Virulence of Subtype IE Venezuelan Equine Encephalitis Viruses Isolated during the 1993 and 1996 Mexican Epizootics
Table 2
Horse no. | Gender | Virus strain | Maximum temperature (°C) | Maximum viremia levela | Clinical outcome | Histopathologic findings |
---|---|---|---|---|---|---|
1 | Male | OAX131 | 40.3 | 2.8 | No disease | Perivascular cuffing, minimal encephalitis |
2 | Male | OAX131 | 40.2 | 1.4 | No disease | Perivascular cuffing, minimal encephalitis |
3 | Male | OAX131 | 39.1 | 1.4 | No disease | Perivascular cuffing, minimal encephalitis |
4 | Male | CPA201 | 40.8 | 2.4 | Fatal encephalitis | Perivascular cuffing, lymphocytic meningitis, focal encephalitis |
5 | Male | CPA201 | 38.4 | 1.4 | No disease | Normal |
6 | Female | CPA201 | 37.7 | <0.6 | No disease | Normal |
7 | Male | OAX142 | 38.2 | <0.6 | No disease | Normal |
8 | Female | OAX142 | 38.9 | <0.6 | No disease | Normal |
9 | Male | I-290–93 | 38.6 | <0.6 | No disease | Normal |
10 | Male | I-290–93 | 39.8 | <0.6 | No disease | Normal |
aTiters expressed as log10 suckling mouse intracerebral lethal dose50/mL serum.
Page created: December 07, 2010
Page updated: December 07, 2010
Page reviewed: December 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.